Skip Navigation HRSA - Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health System Concerns About HRSA

The HIV/AIDS Program: HAB Performance Measures Group 3

 

Mental Health Screening

 

< Previous | Home | Next >

On this page...
 
Performance Measure
 
Numerator
 
Denominator
 
Patient Exclusions
 
Data Element
 
Data Sources
 
National Goals, Targets or Benchmarks for Comparison
 
Outcome Measures for Consideration
 
Basis for Selection and Placement in Group 2
 
US Public Health Service Guidelines
 
References/Notes
 
Performance Measure: Mental Health Screening - OPR-Related Measure: Yes  

Percentage of new clients [ 1 ] with HIV infection who have had a mental health screening

TOP
Numerator  

Number of HIV-infected clients who received a mental health screening

TOP
Denominator  

Number of HIV-infected clients who:

  • were new during the measurement year; and
  • had a medical visit with a provider with prescribing privileges [ 2 ] at least once in the measurement year
TOP
Patient Exclusions  

None

TOP
Data Elements  
  1. Is the client HIV-infected? (Y/N)
    1. If yes, was the client new to the program during the measurement year? (Y/N)
      1. If yes, did the client receive mental health screening during the measurement year?
TOP
Data Sources  
  • Electronic Medical Record/Electronic Health Record
  • CAREWare, Lab Tracker or other electronic data base
  • HIVQUAL reports on this measure for grantee under review
  • Medical record data abstraction by grantee of a sample of records
  • Billing records
TOP
National Goals, Targets, or Benchmarks for Comparison 
National HIVQUAL Data 3 ]
  2003 2004 2005 2006 2007
Top 10%
100.0%
100.0%
80.6%
86.7%
100.0%
Top 25%
93.0%
89.5%
35.1%
52.4%
84.0%
Mean*
68.2%
58.5%
21.9%
28.1%
42.0%

*from HAB data base

TOP
Outcome Measures for Consideration 
  • Rate of mental health referrals
  • Mental health-related hospitalizations
  • Rate of suicide in the clinic population
  • Rate of mental health disorders being treated in the clinic population
TOP
Basis for Selection and Placement in Group 3 

Patients living with HIV infection must often cope with multiple social, psychiatric, and medical issues. The ability to cope with these issues can dramatically impact management of the disease. The initial evaluation should include an assessment of substance abuse, economic factors, social support, mental illness and co-morbidities. 4 ]

The measure was placed in Group 3 because feasibility of data collection can vary considerably across grantees.

TOP
US Public Health Service Guidelines 

"Patients living with HIV infection must often cope with multiple social, psychiatric, and medical issues. Thus, the (initial) evaluation should also include assessment of substance abuse, economic factors, social support, mental illness, co-morbidities, and other factors that are known to impair the ability to adhere to treatment and to alter outcomes. Once evaluated, these factors should be managed accordingly." [ 5 ]

TOP
References/Notes 

[1] "Clients" includes all clients aged 13 years or older.

[2] A "provider with prescribing privileges" is a health care professional who is certified in their jurisdiction to prescribe medications.

[3] The components of the mental health indicator were broken down and implemented for the 2005-2007 data. The Mental Health/Substance Use Subcommittee of the National HIVQUAL Clinical Advisory Committee include the following components for an annual Mental Health Screening for people with HIV: Cognitive function assessment, including mental status; Depression screening; Anxiety screening; Sleeping habits assessment; Appetite assessment; Domestic violence screening; Post Traumatic Stress Disorder screening; Psychiatric history (optional); Psychosocial assessment (optional).
(http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf )

[4] Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. January 29, 2008; 1-128. (http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf )

[5] Ibid.

TOP